Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant
Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these c...
Saved in:
Published in | Europace (London, England) Vol. 17; no. 12; pp. 1823 - 1833 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.12.2015
|
Subjects | |
Online Access | Get full text |
ISSN | 1099-5129 1532-2092 1532-2092 |
DOI | 10.1093/europace/euu374 |
Cover
Abstract | Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts.
Twenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference.
Time to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening. |
---|---|
AbstractList | Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts.AIMSWhether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts.Twenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference.METHOD AND RESULTSTwenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference.Time to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening.CONCLUSIONTime to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening. Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results. This study addresses whether the convention for keeping atrioventricular (AV) delay constant during VV optimization might explain these conflicts. Twenty-two patients in sinus rhythm with existing CRT underwent VV optimization using non-invasive systolic blood pressure. Interventricular optimization was performed with four methods for keeping the AV delay constant: (i) atrium and left ventricle delay kept constant, (ii) atrium and right ventricle delay kept constant, (iii) time to the first-activated ventricle kept constant, and (iv) time to the second-activated ventricle kept constant. In 11 patients this was performed with AV delay of 120 ms, and in 11 at AV optimum. At AV 120 ms, time to the first ventricular lead (left or right) was the overwhelming determinant of haemodynamics (13.75 mmHg at ±80 ms, P < 0.001) with no significant effect of time to second lead (0.47 mmHg, P = 0.50), P < 0.001 for difference. At AV optimum, time to first ventricular lead again had a larger effect (5.03 mmHg, P < 0.001) than time to second (2.92 mmHg, P = 0.001), P = 0.02 for difference. Time to first ventricular activation is the overwhelming determinant of circulatory function, regardless of whether this is the left or right ventricular lead. If this is kept constant, the effect of changing time to the second ventricle is small or nil, and is not beneficial. In practice, it may be advisable to leave VV delay at zero. Specifying how AV delay is kept fixed might make future VV delay research more enlightening. |
Author | Kanagaratnam, Prapa Manisty, Charlotte H. Mayet, Jamil Francis, Darrel P. Sohaib, S.M. Afzal Kyriacou, Andreas Jones, Siana Hughes, Alun D. Whinnett, Zachary I. Peters, Nicholas S. |
Author_xml | – sequence: 1 givenname: S.M. Afzal surname: Sohaib fullname: Sohaib, S.M. Afzal – sequence: 2 givenname: Andreas surname: Kyriacou fullname: Kyriacou, Andreas – sequence: 3 givenname: Siana surname: Jones fullname: Jones, Siana – sequence: 4 givenname: Charlotte H. surname: Manisty fullname: Manisty, Charlotte H. – sequence: 5 givenname: Jamil surname: Mayet fullname: Mayet, Jamil – sequence: 6 givenname: Prapa surname: Kanagaratnam fullname: Kanagaratnam, Prapa – sequence: 7 givenname: Nicholas S. surname: Peters fullname: Peters, Nicholas S. – sequence: 8 givenname: Alun D. surname: Hughes fullname: Hughes, Alun D. – sequence: 9 givenname: Zachary I. surname: Whinnett fullname: Whinnett, Zachary I. – sequence: 10 givenname: Darrel P. surname: Francis fullname: Francis, Darrel P. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25855674$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ksuO1TAMhis0iLnAmh3Kkk2ZNGmaZoOERsNFGokNrKM0cU8DbVKS9KDOc_JApOfMQVzEypbs7_8t25fFmfMOiuJ5hV9VWNBrWIKflYacLJTXj4qLilFSEizIWc6xECWriDgvLmP8gjHmRLAnxTlhLWMNry-KH7d7a8BpQGlQCWnv-tHqhALsVDDW7VC094B8jwYFkzerU5PVuRxn72KmPLIuQdiDS8HqZVQBGRjVivyc7GTvVbLebbze9NQBXZ0egnenYhogqHlFU6ZUsFm1D35CxvY9hG22mD3Q4L8jlT38v1Y2oq8wH6aPSbn0tHjcqzHCs4d4VXx-e_vp5n159_Hdh5s3d6Wmgqay0byrSFtjDg3uayBAhMEtM0w0WHDa6S4viRGFO6PbipmWkYZCa4TqMe8YvSpeH3XnpZvA6G0wNco52EmFVXpl5Z8VZwe583tZ83wKirPAyweB4L8tEJOcbNQwjsqBX6KsOKsZIZTz3Prid69fJqdT5gZ2bNDBxxigl9qmw4KztR1lheX2MvL0MvL4Mpm7_os7Sf-P-AnaANE1 |
CitedBy_id | crossref_primary_10_1111_jce_15862 crossref_primary_10_1016_j_hrtlng_2020_07_004 crossref_primary_10_1007_s10840_020_00908_6 crossref_primary_10_1161_CIRCEP_116_004927 crossref_primary_10_1111_jce_14001 crossref_primary_10_1016_j_jacep_2016_02_012 crossref_primary_10_1161_CIRCEP_122_011181 crossref_primary_10_1007_s00399_019_0616_0 crossref_primary_10_1007_s11886_015_0641_5 crossref_primary_10_1093_europace_euac245 crossref_primary_10_1371_journal_pone_0275276 crossref_primary_10_1080_14779072_2018_1427582 crossref_primary_10_1016_j_hrthm_2024_09_012 crossref_primary_10_1016_j_hjc_2017_11_003 crossref_primary_10_1111_pace_14434 |
Cites_doi | 10.1016/j.jcmg.2013.11.001 10.1111/pace.12065 10.1093/europace/eul017 10.1016/0140-6736(92)92492-X 10.1016/j.ijcard.2013.01.216 10.1016/j.ahj.2013.03.021 10.1016/j.hrthm.2006.09.007 10.1093/europace/eun177 10.1111/j.1540-8159.2010.02933.x 10.1136/hrt.2005.080721 10.1093/europace/eus059 10.4236/am.2011.212212 10.1161/CIRCEP.111.964205 10.1016/j.ijcard.2007.08.004 10.1056/NEJMoa050496 10.1007/s10741-010-9203-5 10.1016/j.ijcard.2012.03.128 10.1016/j.jacc.2011.12.030 10.1093/eurjhf/hft139 10.1016/j.jacc.2005.08.032 10.1056/NEJMoa032423 10.1016/j.jacc.2014.06.1175 10.1093/europace/eus222 10.1016/j.ahj.2005.08.019 10.1016/j.jcmg.2012.07.010 10.1136/heartjnl-2012-301877b.3 10.1093/europace/euq167 10.1161/CIRCULATIONAHA.106.634444 |
ContentType | Journal Article |
Copyright | The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology 2015 |
Copyright_xml | – notice: The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. – notice: The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology 2015 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1093/europace/euu374 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-2092 |
EndPage | 1833 |
ExternalDocumentID | PMC4700730 25855674 10_1093_europace_euu374 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GrantInformation_xml | – fundername: British Heart Foundation grantid: FS/11/92/29122 – fundername: British Heart Foundation grantid: RG/10/11/28457 – fundername: British Heart Foundation grantid: FS/08/027/24763 – fundername: British Heart Foundation grantid: FS/13/44/30291 – fundername: British Heart Foundation grantid: FS/14/27/30752 – fundername: British Heart Foundation grantid: FS/10/038 – fundername: British Heart Foundation grantid: FS/10/38/28268 – fundername: British Heart Foundation grantid: SP/10/002/28189 |
GroupedDBID | --- --K .2P .I3 .XZ .ZR 0R~ 1B1 1TH 29G 2WC 4.4 48X 53G 5GY 5VS 5WA 6PF 70D AABZA AACZT AAJKP AAJQQ AAMVS AAOGV AAPNW AAPQZ AAPXW AAUAY AAUQX AAVAP AAWTL AAYXX ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABNHQ ABNKS ABPQP ABPTD ABQLI ABVGC ABWST ABXVV ABZBJ ACGFS ACPRK ACUFI ACUTO ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADOCK ADRTK ADVEK ADYVW ADZXQ AEGPL AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGQXC AGSYK AGUTN AHMBA AHXPO AIJHB AJEEA ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX AMNDL APIBT APWMN AXUDD BAWUL BAYMD BEYMZ BHONS BTRTY BVRKM C1A CAG CDBKE CITATION COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EJD EMOBN ENERS F5P F9B FECEO FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HW0 HZ~ IHE IOX J21 JXSIZ KBUDW KOP KQ8 KSI KSN M-Z M41 MHKGH N9A NGC NOMLY NOYVH NQ- NTWIH NU- O0~ O9- OAUYM OAWHX ODMLO OJQWA OJZSN OK1 OPAEJ OVD P2P PAFKI PEELM PQQKQ Q1. Q5Y RD5 RIG ROL RPM RPZ RUSNO RW1 RXO SEL SV3 TCURE TEORI TJX TOX TR2 UHS VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c393t-6c7b128407e60f4e2e29d085d5960973bcb56752a0bdc815d85263e8d9af07b53 |
ISSN | 1099-5129 1532-2092 |
IngestDate | Thu Aug 21 14:05:31 EDT 2025 Thu Jul 10 17:28:12 EDT 2025 Mon Jul 21 05:57:17 EDT 2025 Tue Jul 01 04:19:06 EDT 2025 Thu Apr 24 23:04:59 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Heart failure Mechanisms Physiology Cardiac resynchronization therapy |
Language | English |
License | The Author 2015. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c393t-6c7b128407e60f4e2e29d085d5960973bcb56752a0bdc815d85263e8d9af07b53 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC4700730 |
PMID | 25855674 |
PQID | 1754522377 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700730 proquest_miscellaneous_1754522377 pubmed_primary_25855674 crossref_citationtrail_10_1093_europace_euu374 crossref_primary_10_1093_europace_euu374 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-12-01 |
PublicationDateYYYYMMDD | 2015-12-01 |
PublicationDate_xml | – month: 12 year: 2015 text: 2015-12-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Europace (London, England) |
PublicationTitleAlternate | Europace |
PublicationYear | 2015 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 2016010504271958000_17.12.1823.15 2016010504271958000_17.12.1823.14 2016010504271958000_17.12.1823.17 2016010504271958000_17.12.1823.16 2016010504271958000_17.12.1823.19 2016010504271958000_17.12.1823.18 2016010504271958000_17.12.1823.11 2016010504271958000_17.12.1823.10 2016010504271958000_17.12.1823.13 2016010504271958000_17.12.1823.12 2016010504271958000_17.12.1823.7 2016010504271958000_17.12.1823.8 2016010504271958000_17.12.1823.5 2016010504271958000_17.12.1823.6 2016010504271958000_17.12.1823.9 2016010504271958000_17.12.1823.26 2016010504271958000_17.12.1823.25 2016010504271958000_17.12.1823.28 2016010504271958000_17.12.1823.27 2016010504271958000_17.12.1823.20 2016010504271958000_17.12.1823.3 2016010504271958000_17.12.1823.22 2016010504271958000_17.12.1823.4 2016010504271958000_17.12.1823.21 2016010504271958000_17.12.1823.1 2016010504271958000_17.12.1823.24 2016010504271958000_17.12.1823.2 2016010504271958000_17.12.1823.23 |
References_xml | – ident: 2016010504271958000_17.12.1823.27 doi: 10.1016/j.jcmg.2013.11.001 – ident: 2016010504271958000_17.12.1823.11 doi: 10.1111/pace.12065 – ident: 2016010504271958000_17.12.1823.12 doi: 10.1093/europace/eul017 – ident: 2016010504271958000_17.12.1823.15 doi: 10.1016/0140-6736(92)92492-X – ident: 2016010504271958000_17.12.1823.16 doi: 10.1016/j.ijcard.2013.01.216 – ident: 2016010504271958000_17.12.1823.6 doi: 10.1016/j.ahj.2013.03.021 – ident: 2016010504271958000_17.12.1823.4 doi: 10.1016/j.hrthm.2006.09.007 – ident: 2016010504271958000_17.12.1823.3 doi: 10.1093/europace/eun177 – ident: 2016010504271958000_17.12.1823.19 doi: 10.1111/j.1540-8159.2010.02933.x – ident: 2016010504271958000_17.12.1823.5 doi: 10.1136/hrt.2005.080721 – ident: 2016010504271958000_17.12.1823.9 doi: 10.1093/europace/eus059 – ident: 2016010504271958000_17.12.1823.21 doi: 10.4236/am.2011.212212 – ident: 2016010504271958000_17.12.1823.22 doi: 10.1161/CIRCEP.111.964205 – ident: 2016010504271958000_17.12.1823.14 doi: 10.1016/j.ijcard.2007.08.004 – ident: 2016010504271958000_17.12.1823.17 doi: 10.1056/NEJMoa050496 – ident: 2016010504271958000_17.12.1823.13 doi: 10.1007/s10741-010-9203-5 – ident: 2016010504271958000_17.12.1823.20 doi: 10.1016/j.ijcard.2012.03.128 – ident: 2016010504271958000_17.12.1823.23 doi: 10.1016/j.jacc.2011.12.030 – ident: 2016010504271958000_17.12.1823.24 doi: 10.1093/eurjhf/hft139 – ident: 2016010504271958000_17.12.1823.7 doi: 10.1016/j.jacc.2005.08.032 – ident: 2016010504271958000_17.12.1823.18 doi: 10.1056/NEJMoa032423 – ident: 2016010504271958000_17.12.1823.25 doi: 10.1016/j.jacc.2014.06.1175 – ident: 2016010504271958000_17.12.1823.1 doi: 10.1093/europace/eus222 – ident: 2016010504271958000_17.12.1823.10 doi: 10.1016/j.ahj.2005.08.019 – ident: 2016010504271958000_17.12.1823.26 doi: 10.1016/j.jcmg.2012.07.010 – ident: 2016010504271958000_17.12.1823.28 doi: 10.1136/heartjnl-2012-301877b.3 – ident: 2016010504271958000_17.12.1823.2 doi: 10.1093/europace/euq167 – ident: 2016010504271958000_17.12.1823.8 doi: 10.1161/CIRCULATIONAHA.106.634444 |
SSID | ssj0007295 |
Score | 2.2113595 |
Snippet | Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 1823 |
SubjectTerms | Action Potentials Atrioventricular Node - physiopathology Blood Pressure Cardiac Resynchronization Therapy - adverse effects Cardiac Resynchronization Therapy - methods Clinical Research Electrocardiography Electrophysiologic Techniques, Cardiac Female Heart Block - diagnosis Heart Block - physiopathology Heart Block - therapy Heart Failure - diagnosis Heart Failure - physiopathology Heart Failure - therapy Heart Rate Hemodynamics Humans Male Time Factors Treatment Outcome |
Title | Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant |
URI | https://www.ncbi.nlm.nih.gov/pubmed/25855674 https://www.proquest.com/docview/1754522377 https://pubmed.ncbi.nlm.nih.gov/PMC4700730 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1bb9MwFICtMiTECxr3MkBG4gEpSpcmcS6PE9o02Doe2kp9i2zHoRFrM62pUPs7-RH8DI5vWXpBGrxEURLHac-X-Bz7XBD6SDmjSSGrBrCUuCFPqJvy2HdznvZzL-U8YjIaeXAVnY_DrxMy6XR-t7yWljXr8fXeuJL_kSocA7nKKNl_kGxzUzgA-yBf2IKEYXsvGduSoKA9gp3PTYSHcyu-S7nLiYJyreYEplTMqlwXn4fTyi1W1cworcujmgekslr4NV05FXxIZiZCUzmeK45U09Wcq3y65qSO31o5M2gl6xkKHbBi665ofy9nWv10ZC2AarercuH8EDfq6aWiurtUQLnYW3ekNYcxrKa0VAtLQ2fgnBRr2viNXKxADrxaNs6b9M5n0pYpGMIr0oxOAypzCa8aV4SqroWJ4DCTI33ScjSx33MfkNHl9npizzE7CMRt2P3WJx0MsGDvWKPzcAnzT6jdZaBLDm3m9b76lp2NLy-z0elk9AA99GPQ8qT6_uWi0RnAxCE6s69-NJuEKg2ObQfH-vab-tOOUbTt29tSlkaH6ImxcvCJRvYp6oj5M_RoYPw4nqNfllwsycWWXNyQiyW5uCpwm1xsycV1hbfJxQon3CZXtjfk4h1ysSEXA7lYkYslubhFLvSBgVy8Ta7pqlxgSS625L5A47PT0edz19QXcXmQBrUb8ZhJ9cyLReQVofCFn-ZgguREpmGMA8YZAXvapx7LedIneUL8KBBJntLCixkJXqKDOaD6GmGein7KKO2DOh6GUZKGJGR5wfwwYWByeF3Us1LLuEm-L2vAXGfaCSTIrJgzLeYu-tQ0uNF5Z_5-6QeLQQZjg1zwo3NRLRcZmAayYEIQx130SmPR3MwnCYFfB63jDWCaC2Te-c0z83Kq8s-HsVzf997co98j9PjutXyLDurbpXgHWnzN3qsX4A8wngpH |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Evidence+that+conflict+regarding+size+of+haemodynamic+response+to+interventricular+delay+optimization+of+cardiac+resynchronization+therapy+may+arise+from+differences+in+how+atrioventricular+delay+is+kept+constant&rft.jtitle=Europace+%28London%2C+England%29&rft.au=Sohaib%2C+S+M+Afzal&rft.au=Kyriacou%2C+Andreas&rft.au=Jones%2C+Siana&rft.au=Manisty%2C+Charlotte+H&rft.date=2015-12-01&rft.issn=1532-2092&rft.eissn=1532-2092&rft.volume=17&rft.issue=12&rft.spage=1823&rft_id=info:doi/10.1093%2Feuropace%2Feuu374&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1099-5129&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1099-5129&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1099-5129&client=summon |